Status:

COMPLETED

BRUSH Sign: Radiolographic Marker of Cerebral Infarctus Prognosis

Lead Sponsor:

Fondation Hôpital Saint-Joseph

Conditions:

Cerebral Infarction

Eligibility:

All Genders

18+ years

Brief Summary

Today the treatment of ischemic stroke in acute phase is based on medicinal or endovascular revascularization. Cerebral MRI sequences help the diagnostic. This procedure uses deoxyhemoglobin as an end...

Eligibility Criteria

Inclusion

  • age\>18 years old
  • hospitalized for cerebral infarction
  • MCA territory
  • MRI within 24hours
  • Sequence of magnetic susceptibility (SWAN)

Exclusion

  • Incomplete cerebral infarct
  • MRI not possible

Key Trial Info

Start Date :

February 24 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 30 2017

Estimated Enrollment :

250 Patients enrolled

Trial Details

Trial ID

NCT03467269

Start Date

February 24 2017

End Date

June 30 2017

Last Update

March 15 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Groupe Hospitalier Paris Saint Joseph

Paris, Île-de-France Region, France, 75014